Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

This article is part of the supplement: Proceedings of the 7th Romanian National HIV/AIDS Congress and The 2nd Central European HIV Forum

Open Access Poster presentation

Assessment of neurocognitive impairment in HIV-infected patients from the Regional Center Mureş

Mariana Georgescu*, Carmen Chiriac, Erzsébet Iringó Zaharia-Kézdi and Nina Șincu

  • * Corresponding author: Mariana Georgescu

Author Affiliations

Infectious Diseases Clinic I, Tîrgu Mureş County Clinic Hospital, Tîrgu Mureş, Romania

For all author emails, please log on.

BMC Infectious Diseases 2014, 14(Suppl 4):P37  doi:10.1186/1471-2334-14-S4-P37

The electronic version of this article is the complete one and can be found online at:

Published:29 May 2014

© 2014 Georgescu et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Poster presentation

Neurocognitive assessment in HIV-infected patients in Regional Center Mureş was held between 01.01.2013-31.12.2013 on a group of 26 patients. Out of the 26 patients recruited and evaluated, all were included in the national database and 6 patients were recommended for comprehensive assessment at the “Victor Babeş” Hospital - Bucharest. Inclusion criteria: patients born between 1987-1991, at least 8 years of education, who had not been institutionalized, without psychiatric conditions.

We used the following methods for neurocognitive screening of patients included in our study: International HIV Dementia Scale, Simioni questionnaire, Beck Depression Inventory, Patient’s Assessment of Own Functioning Inventory (PAOFI).

Preliminary psychological evaluation in 26 patients showed no evidence of neurocognitive deficit. Out of the 6 patients who underwent comprehensive neurocognitive testing, 1 patient was diagnosed with neurocognitive deficit, obtaining lower values than the group’s average for most tested areas.

It is necessary to validate a tool to identify the neurocognitive changes caused by HIV. The final results will be given by the National Screening Program.